PRA Health Sciences Opens New Bioanalytical Laboratory in the Netherlands
(Thomson Reuters ONE) -
RALEIGH, N.C., Oct. 26, 2015 (GLOBE NEWSWIRE) -- PRA Health Sciences (PRA)
(NASDAQ:PRAH) is pleased to announce the opening of its brand new, state-of-the-
art Bioanalytical Laboratory in Assen, the Netherlands. The 33,000 square foot
facility provides 25 percent more space than PRA's previous lab, includes
investments in the newest small and large molecule equipment, and allows for
optimal bioanalytical process efficiencies. The new laboratory is also located
close to PRA's Phase I clinics in Groningen and Zuidlaren, providing easy access
and analysis of the most time-critical samples and execution of adaptive trials.
"We are proud to offer our clients industry-leading, high quality, high science
laboratory services in this new and innovative environment," said Peter
Ketelaar, PRA Vice President of Global Bioanalytical Laboratory Services. "The
new facility is a testament to PRA's commitment to excellence and our passion to
advance clinical development."
PRA bioanalytical laboratories have 30+ years of experience in providing
bioanalytical services in support of clinical and pre-clinical trials for both
small and large molecules. Industry leading experts with a depth of scientific
and regulatory knowledge and experience manage and support PRA's laboratory
services, contributing to successful development of new medicines.
"Our technology investments and innovative services operations are what set PRA
apart in the industry," said PRA CEO Colin Shannon. "We take enormous pride in
the expertise we bring to the table that enables us to excel at clinical
research and deliver quality results for our clients and patients."
PRA operates GLP-compliant (Good Laboratory Practice) and fully harmonized
bioanalytical laboratories in the Netherlands and the Unites States (Lenexa,
Kansas). Both are strategically located near PRA's clinical research units to
enable close collaboration and faster drug development decision making.
ABOUT PRA HEALTH SCIENCES
At PRA Health Sciences, providing innovative solutions for our clients is what
we do. Side-by-side with our clients, we strive to move drug discovery forward,
helping them to develop life-saving and life-improving drugs. PRA has more than
11,000 employees working in 80+ countries providing comprehensive clinical
development services across all phases. From full service clinical development
to the pioneering Embedded Solutions(TM) model, PRA provides a broad spectrum of
solutions that meet the demands of a diverse marketplace. PRA has worked on
100+ marketed drugs across several therapeutic areas and conducted the pivotal
or supportive trials that led to FDA and/or international regulatory approval of
50+ such drugs.
INQUIRIES: Christine Rogers, Manager -
Public Relations, Corporate Communications
EMAIL: rogerschristine(at)prahs.com PHONE: +1 919.786.8463
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: PRA Health Sciences via GlobeNewswire
[HUG#1961028]
Datum: 26.10.2015 - 14:00 Uhr
Sprache: Deutsch
News-ID 429379
Anzahl Zeichen: 3703
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 280 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"PRA Health Sciences Opens New Bioanalytical Laboratory in the Netherlands"
steht unter der journalistisch-redaktionellen Verantwortung von
PRA Health Sciences (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
